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Summary
Correlated samples have been frequently avoided in case-control genetic association studies
in part because the methods for handling them are either not easily implemented or not widely
known. We advocate one method for case-control association analysis of correlated samples –
the effective sample size method – as a simple and accessible approach that does not require
specialized computer programs. The effective sample size method captures the variance in-
flation of allele frequency estimation exactly, and can be used to modify the chi-square test
statistic, p-value, and 95% confidence interval of odds-ratio simply by replacing the apparent
number of allele counts with the effective ones. For genotype frequency estimation, although
a single effective sample size is unable to completely characterize the variance inflation, an
averaged one can satisfactorily approximate the simulated result. The effective sample size
method is applied to the rheumatoid arthritis siblings data collected from the North Amer-
ican Rheumatoid Arthritis Consortium (NARAC) to establish a significant association with
the interferon-induced helicasel gene (IFIH1) previously being identified as a type 1 diabetes
susceptibility locus. Connections between the effective sample size method and other methods,
such as generalized estimation equation, variance of eigenvalues for correlation matrices, and
genomic controls, are also discussed.
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Introduction
One of the major obstacles in statistical analysis of genetic association studies in a case-
control setting is the violation of the independence assumption. Dependence or correlation
between markers due to linkage disequilibrium causes problems in applying Bonferroni cor-
rections for multiple testing. Dependence between samples, such as members from the same
family, invalidates a basic assumption in many statistical tests, thus potentially making the
p-value estimation unreliable. As dependence has been an important theme in statistics for
many years, there is large amount of literature in genetics as well as in statistics to tackle the
problem – for example, the maximum likelihood estimation of allele frequencies in relatives
(Boehnke, 1991; Thomas and Camp, 2006); the use of principal components or eigenvectors
to identify clusters of samples (Price et al. 2006; Patternson et al., 2006), or to reduce the
effective number of markers in a linkage disequilibrium block (Cheverud 2001; Nyholt 2004);
sample weighting to suppress contributions from correlated samples (Broman 2001; Browning
et al., 2005), etc. In yet another example, the framework of generalized estimating equation
proposed by Liang and Zeger estimates correlation structure from the data when the nature
of relatedness between samples is unknown (Liang and Zeger 1986; Hanley et al., 2003).
The transition from genetic linkage analyses to association studies (Risch and Merikangas,
1996; Li et al., 2005) presents a situation when affected sibs or affected pedigree members are
often used as case samples in a case-control association study. Since the correlation structure
between sibs or relatives is given, it is not necessary to use techniques such as the generalized
estimating equation as has been carried out in (Silverberg et al., 2003). Instead, variance
of correlated samples can be calculated (Slager and Schaid, 2001) and its effect on the test
statistic can be determined. The method discussed in (Slager and Schaid, 2001) is however
only applied to the Armitage trend test.
Intuitively, positive correlation between samples reduces the “effective” sample size com-
pared to the apparent sample size. Take an extreme example of monozygotic twins: since
monozygotic twins have identical genotypes, the effective sample size should be one versus the
apparent sample size of two. On the other hand, positive correlation between a few samples in
a dataset leads to an increase of the variance. These concepts have already been understood
in the study of clustered/clumped data (Williams, 2000), and are associated with phrases like
“variance inflation” (Hsieh et al. 2003) and “overdispersion” (Efron 1986; Condon et al., 2004).
In this paper, we advocate the use of “effective sample size” (ESS) as a simple method
to capture the effect of sample correlation and variance inflation. The term effective sample
size has appeared in the literature before (Kish 1965; Thie´baux and Zwiers, 1984; Rosner
and Milton, 1988; Rao and Scott, 1992; Madden and Hughes, 1999) but has not become a
commonly used tool in genetic analysis. We define effective sample size Ne as the equivalent
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number of independent samples that leads to the same variance of an intensive quantity, i.e., a
quantity that does not change with the sample size. For example, if the sample proportion of
heads in a coin tossing is estimated to be p, its variance is p(1− p)/N where N is the number
of coin tosses; if the observed variance is larger than what is expected from this equation, and
can be fitted by the formula p(1− p)/Ne, then Ne is the effective sample size.
In genetic case-control studies, the association signal originates from the allele or genotype
frequency difference in the diseased and the normal group. The estimation of allele or genotype
frequency is very much like the estimation of heads proportion in the tossing coin example given
above. We will show that for allele frequency, effective sample size captures the effect of sample
correlation exactly. Even for situations where the effective sample size does not provide an
exact solution, for example, in estimating genotype frequencies, an averaged parameter usually
leads to good approximation. Because the calculation of test statistics X2, p-value, and power
all directly involve sample size, replacing the apparent sample size with the effective sample
size is a quick and convenient solution to the problem of correlated samples without the need
to use a custom program.
Mathematical Details
Effective sample size for sibpairs
For simplicity, let’s first consider Nsib sibpairs. For the quantity of interest xi (i = 1, 2, · · ·2Nsib,
the 2Nsib × 2Nsib correlation matrix for xi is:
R =


1 r 0 0 .
r 1 0 0 .
0 0 1 r .
0 0 r 1 .
. . . . .


(1)
Each 2-by-2 sub-matrix in Eq.(1) represents a sibpair with off-diagonal element r being the
correlation coefficient Cor(xi, xi+1) between two sibs i and i+1. The variance of the extensive
variable X =
∑
i xi is then equal to the weighted sum:
V arX =
∑
ij
σiσjRij
where σi and σj is the standard deviation of x for person i and j, and the variance of the
intensive quantity x =
∑
i xi/(2Nsib) is
V arx =
∑
ij
σiσjRij/(2Nsib)
2
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Since here we are dealing with sibpairs of the same affection status, σi = σj = σ, which
simplifies the variance for the correlation matrix in Eq.(1):
V arX = Nsib · σ
2 · 2(1 + r) and V arx =
σ2(1 + r)
2Nsib
The equivalent number independent samples that lead to the same variance for x can be derived
by equating σ2 · 2(1 + r)/(2Nsib) = σ
2/Ne, or, the ESS for sibpairs is:
Ne =
2Nsib
1 + r
. (2)
The effective sample size reduction α is defined as the ratio between the ESS and the apparent
sample size, and for sibpairs, it is equal to:
α ≡
Ne
2Nsib
=
1
1 + r
. (3)
Effective sample size for larger sibships
For Ntri pedigrees each with three siblings, the 3Ntri × 3Ntri correlation matrix can be written
as:
R =


1 r r 0 0 0 .
r 1 r 0 0 0 .
r r 1 0 0 0 .
0 0 0 1 r r .
0 0 0 r 1 r .
0 0 0 r r 1 .
. . . . . . .


(4)
and the variance of x, ESS, and sample size reduction are:
V arx =
σ2(1 + 2r)
3Ntri
, Ne =
3Ntri
1 + 2r
and α =
1
1 + 2r
. (5)
More generally, for sibship of k sibs, the sample size reduction is
α =
1
1 + (k − 1)r
. (6)
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Effective sample size for a mixture of relatives
For pedigrees with a specific mixture of relatives, for example, two sibs and one uncle, the
correlation matrix consists of identical sub-blocks:
R =


1 r1 r2 0 0 0 .
r1 1 r2 0 0 0 .
r2 r2 1 0 0 0 .
0 0 0 1 r1 r2 .
0 0 0 r1 1 r2 .
0 0 0 r2 r2 1 .
. . . . . . .


where r1 is the correlation coefficient between two sibs, and r2 is that between a sib and the
uncle. It can be shown that the sample size reduction is
α =
3
3 + 2r1 + 4r2
=
1
1 + 2r
(7)
where the averaged correlation r = (1/3)r1 + (2/3)r2 is defined in such a way that we can
assume all relatives were similar and any two relatives have a correlation coefficient of r. The
similar derivation can be generalized to any combination of relatives.
Correlation coefficient of two relatives’ allele counts
The correlation coefficient between allele count x (x=2,1,0 for marker genotype AA,AB,BB,
with probability of p2, 2pq, q2) of two sibs is:
r ≡
Cov[xsib1, xsib2]√
V ar[xsib1]
√
V ar[xsib2]
=
E[xsib1, xsib2]−E[x]
2
V ar[x]
.
The mean and variance of the number of alleles is E[x] = 2p, V ar[x] = 2pq, and the joint
probability E[xsib1, xsib2] can be calculated by the Li-Sacks conditional probability given the
identity-by-descent (IBD) status (Li and Sacks, 1954; Li, 1998; Li and Reich, 2000; Dai and
Weeks, 2006). The three Li-Sacks matrices (the so called ITO matrices) are the probability of
the second relative to have one of the genotypes given the genotype of the first relative, and
given the IBD status between the two relatives:
IBD=2 IBD=1 IBD=0
I =


1 0 0
0 1 0
0 0 1

 , T =


p q 0
p/2 1/2 q/2
0 p q

 , O =


p2 2pq q2
p2 2pq q2
p2 2pq q2

 .
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By using the ITO matrices, we have (pik is the probability of k copies of IBD alleles between
two relatives):
E[xrel1, xrel2] =
2∑
i,j=0
i · j · P (xrel1 = i, xrel2 = j) =
2∑
i,j=0
ij
2∑
k=0
P (xrel2 = j|i, k)pikP (xrel1 = i)
= pi04p
2 + pi1(4p
2 + pq) + pi2(4p
2 + 2pq) = 4p2 + pq(pi1 + 2pi2).
Inserting it back to the correlation coefficient formula, we have:
r =
4p2 + pq(pi1 + 2pi2)− 4p
2
2pq
=
pi1
2
+ pi2
The probability that a randomly selected allele from one relative is IBD with a randomly
selected allele from another relative, called kinship coefficient Φ, is equal to Φ = pi2(1/2) +
pi1(1/4) (Male´cot, 1948; Langer, 1997). The correlation coefficient r is twice the value of kinship
coefficient: r = 2Φ. The same relationship was derived more tediously in, e.g., (Broman, 2001)
without using the ITO matrices.
Correlation coefficient of two relatives’ genotype indicator variable
Genotype indicator variable x is 1 for a particular genotype of interest, and 0 for other geno-
types. For example, x=1,0,0 for AA,AB,BB is the indicator variable for the homozygous
genotype AA. Using the same ITO matrices, the joint probability for AA-indicator variable x
between two relatives is
E[xrel1, xrel2] = P (xrel1 = 1, xrel2 = 1) =
2∑
k=0
P (xrel2 = 1|1, k)pikP (xrel1 = 1)
= p2(pi2 + pi1p+ pi0p
2)
and correlation coefficient is:
rAA−indicator =
p2(pi2 + pi1p+ pi0p
2)− (p2)2
p2(1− p2)
=
pi2 + pi1p+ (pi0 − 1)p
2
1− p2
(8)
Similarly, for AB and BB indicator variable,
rAB−indicator =
pi2 + pi1/2 + (pi0 − 1)2pq
1− 2pq
rBB−indicator =
pi2 + pi1q + (pi0 − 1)q
2
1− q2
(9)
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Correcting X2 test statistic and 95% confidence interval of odds-ratio by the ef-
fective sample size
Single-marker case-control association analysis can be carried out with chi-square test, odds-
ratio (OR), and confidence interval of OR. Typically, the control samples are randomly col-
lected from a normal population with no need for correcting correlated samples, whereas case
samples might be collected during the linkage analysis stage, thus are correlated. For allele-
based analysis (Sasieni, 1997), denote the allele counts in case group as NA,case, NB,case and
those in control group as NA,con, NB,con, the Pearson’s chi-square test statistic can be recalcu-
lated by replacing NA,case, NB,case with αNA,case and αNB,case:
X2e =
α(NA,caseNB,con −NB,caseNA,con)
2(αNA,case + αNB,case +NA,con +NB,con)
(NA,case +NB,case)(NA,con +NB,con)(αNA,case +NA,con)(αNB,case +NB,con)
. (10)
The modified test statistic X2e can then be used to determined the p-value.
For OR θˆ = NA,caseNB,con/(NA,conNB,case), the uncorrected 95% confidence interval (CI) is
estimated by the Woolf’s formula: [l, u] = [elog θˆ−1.96σˆ(log θˆ), elog θˆ+1.96σˆ(log θˆ)], with σˆ(log θˆ) =
(1/NA,case + 1/NB,case + 1/NA,con + 1/NB,con)
0.5. This can be corrected in a similar way by
replacing NA,case, NB,case with αNA,case and αNB,case:
σˆe(log θˆ) =
(
1
αNA,case
+
1
αNB,case
+
1
NA,con
+
1
NB,con
)1/2
. (11)
It can be shown that α < X2e/X
2 < 1 and σˆe/σˆ > 1, when α < 1. In other words, when
the effective sample size is smaller than the apparent sample size, the test statistic is smaller
(leading to larger p-values), and the 95% CI of OR is wider.
Results
Diminishing return in adding more relatives from the same pedigree in an associ-
ation study
The kinship coefficients and sample size reduction with respect to allele frequency estimation
of common relative pairs are listed in Table 1, and those for sibships with 1,2, . . . siblings
are listed in Table 2. For more complicated relationships or pedigrees with loop, one can
consult (Maruyama and Yasuda, 1970; Lange 1997). Several rules-of-thumb can be stated: two
siblings contribute 1.333 samples, uncle-nephew pair contributes 1.6 samples, three siblings are
equivalent to 1.5 samples, etc. If the relationship between two pedigree members is distant, the
correlation is close to zero and they can be treated as two independent samples (e.g., second
cousins contribute 1.94 samples). For larger sibship, there is a diminishing return in adding
extra sibs: adding the second, the third, the fourth, and the fifth sibs only adds 0.333, 0.167,
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Yang, Gregersen, Li 9
0.1, 0.067 samples. Even in the limit of infinite number of sibs, the effective sample size can
not be larger than 2, as the extra sibs merely resample the finite pool of four parental alleles.
These results show that while one should include as many samples as possible, whether
correlated or not, in an association study, it does not seem necessary to include too many
relatives from the same pedigree. While distant relatives are essentially independent samples,
for close relatives such as siblings, two persons are perhaps a good compromise between the
desire to add more samples and the diminishing return due to correlations.
When a mixture of relatives from the same pedigree is included, one can use the averaged
correlation coefficient discussed in the Method section. For example, with two siblings and one
aunt/uncle, the averaged correlation coefficient r = (1/3)0.5 + (2/3)0.25 = 1/3. The ESS for
the two-sib-one-uncle is 1.8, larger than the value of 1.6 for three siblings.
pair relationship pi2 pi1 pi0 Φ r α Ne
parent-child 0 1 0 1/4 1/2 2/3 4/3 ≈ 1.333
sibs 1/4 1/2 1/4 1/4 1/2 2/3 4/3 ≈ 1.333
half-sibs 0 1/2 1/2 1/8 1/4 4/5 8/5 = 1.6
uncle/aunt-nephew/niece 0 1/2 1/2 1/8 1/4 4/5 8/5 =1.6
first cousins 0 1/4 3/4 1/16 1/8 8/9 16/9 ≈ 1.778
second cousins 0 1/16 15/16 1/64 1/32 32/33 64/33 ≈ 1.939
Table 1: For several common relative pairs, these quantities are listed: pi2, pi1, pi0: probabilities of 2,1,0 copies of
allele that are identity-by-descent (IBD); Φ: kinship coefficient; r: correlation coefficient between the number
of allele A (or B) counts; α: sample size reduction; Ne: effective number of samples in the relative pair.
size of sibship α Ne
2 2/3 4/3 ≈ 1.333
3 1/2 3/2=1.5
4 2/5 8/3=1.6
5 1/3 5/3 ≈ 1.667
k 2/(k+1) 2k/(k + 1) ≈ 2(1− 1/k)
Table 2: The sample size reduction α and effective sample size Ne of sibships with 2, 3, 4, 5, and k sibs.
Improving p-value by using all samples
For the PTPN22 data in Table 4, if one affected sib per sibpair is selected for association as
in (Begovich et al., 2004), X2 = 31.42 leads to p-value of 2.1 ×10−8 (with Fisher’s exact test,
the p-value is 5.6 ×10−8), and 95%CI of OR is (1.55-2.50). We know this is an underuse of
the samples as the second sibs in sibpairs were discarded. Using all sibs in sibpairs without
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Yang, Gregersen, Li 10
correction leads to the incorrect result of X2 =53.26, p-value of 2.9 ×10−13, and 95% CI of
OR of (1.73-2.62). The overall ratio of effective sample size and the apparent sample size is:
α = (86 + 377 × 2 × 2/3)/(866 + 377 × 2) ≈ 0.70. Using the Eq.(10) and Eq.(11), the
modified X2 = 45.73 leads to p-value of 1.36 ×10−11, and modified 95% CI of OR (1.70-2.66).
Compared to the one-sib-per-pair dataset, even though the conclusion on statistical significance
is unchanged, the p-value is 1500 times smaller.
The ratio of two chi-squares, one for all samples with ESS correction and another without, is
calculated to be X2e/X
2 = 45.73/53.26 = 0.86. This ratio can also be approximately estimated
from ESS. Since X2 and X2e can be written in the form: X
2 = (pˆA,case− pˆA,control)
2/[(1/Ncase +
1/Ncontrol)·p ·q], X
2
e ≈ (pˆA,case− pˆA,control)
2/[(1/(αNcase)+1/Ncontrol)·p·q] (in an approximation,
the pooled allele frequency estimation for A and B is not greatly affected by the change of
sample size), X2e/X
2 ≈ (1/(0.7× 1680) + 1/1852)/(1/1680 + 1/1852) = 0.82.
For the IFIH1 gene in Table 5, we applied the effective sample size method both globally
or pedigree-type-specifically. Using Eqs.(2,5,6,7), and by a conservative use of relatives in
assuming all relatives to be sibships, we have the averaged effective number of allele counts:
2(67+512·2/(1+0.5)+64·3/(1+2×0.5)+8·4/(1+3×0.5)+5/(1+4×0.5)+8/(1+7×0.5)≈ 1724,
or, the average sample reduction of α = 861.9111/1328 ≈ 0.649. The ESS-based method leads
to a p-value of 0.0023 in chi-square test, improved upon the p-value of 0.0179 when only one
case per family is used (second line in Table 5). At the significance level of 0.01, adding
correlated samples in this dataset makes an insignificant result significant.
The SNP minor allele frequency (MAF) for the control population in the IFIH1 gene was
reported to be 40.4% in the initial round, and 38.7% in the follow-up round (Smyth et al.,
2006); that in the type 1 diabetes population was 35.3% in the first round, and 34.0% in
the second round, each with thousands of samples. The control MAF in Table 5 is 40.8%,
consistent with the value in (Smyth et al., 2006). However, the MAF for the rheumatoid
arthritis samples in Table 5 is 36.2%, larger than the MAF for the type 1 diabetes samples.
The weaker association signal in rheumatoid arthritis study as compared to diabetes study
implies a larger sample size requirement for its detection, and as a result, ESS method proves
to be important in incorporating extra sibling samples to increase the sample size.
One can also apply the ESS method to each pedigree-type specifically. We count the T
and C alleles in pedigrees with only affected sibpairs, then reduce the count by the factor
1/(1+0.5) = 2/3. Similarly, the allele counts in pedigrees with three affected sibs are reduced
by the factor of 1/(1 + 2 × 0.5) = 1/2, etc. The pedigree-type-specific allele count reduction
leads to p-value of 0.00467. We can partially explain why this p-value is not as good as the
one derived by the global sample size reduction: the association signal is largely due to an
enrichment of the major allele T in the case group; however, the largest pedigree with 8 affected
members with 13 counts of the T allele leads to an effective contribution in the “local method”
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Yang, Gregersen, Li 11
of 3.3 counts, as versus the 9.7 counts in the “global method”.
A single effective sample size does not capture all variance inflations in genotype
frequency estimations, but it provides a good approximation
With the correlation coefficient for genotype indicator variable in Eq.(8,9), we can derive the
sample size reduction α and variance inflation 1/α for genotype frequencies obtained from
relative pairs, sibships, and cluster of relatives: αG = 1/(1 + rG), 1/(1 + (k − 1)rG), and
1/(1+ (k− 1)rG) respectively, where rG (G=(AA,AB, BB) is the genotype-specific correlation
coefficient. Compared to the variance inflation for allele frequency estimation, the number of
ESSs for genotype frequencies is 3 instead of 1, as rAA, rAB, rBB are not equal to each other.
Furthermore, these correlation coefficients depend on p, q.
We illustrate these properties by the example of sibpairs. Using Eq.(8,9,3), the genotype-
specific sample size reductions are:
αAA,sibpair =
1
1 + (1 + 3p)/(4 + 4p)
αAB,sibpair =
1
1 + (1− 3pq)/(2− 4pq)
αBB,sibpair =
1
1 + (1 + 3q)/(4 + 4q)
. (12)
Figure 1 shows αG,sibpair’s of the three genotypes as a function of p; also shown are the geno-
type frequency variance (multiplied by the sample size). Variances of genotype frequencies
calculated from independent samples are shown in solid lines as a comparison. It can be seen
from Figure 1 that the variance inflation of allele frequency is distinct from those of genotype
frequencies in that its α is a constant value 2/3 independent of p. It illustrates that one should
not expect a single parameter to correct the variance inflation in correlated samples for all
circumstances.
The genotype-specific sample size reductions in Eq.(12) can be applied in the following way:
(1) the allele frequency p is estimated from the data; (2) three αGs are calculated by Eq.(12); (3)
each genotype count is discounted by the genotype-specific αG, then these modified genotype
counts can be used for further genotype-based association. Notice that αG’s in Eq.(12) are
confined to the range (2/3, 4/5). One can also obtain an averaged ESS by averaging over three
genotypes: αavg,sibpair(p) = p
2α1 + 2pqα2 + q
2α3, and αavg,sibpair (p is estimated from the data
first) can be used to discount all three genotype counts by the same factor. In yet another
approach, αavg,sibpair can be averaged over p: α ≡
∫ 1
0
αa(p)dp. This leads to α = 0.7096. One
can use α to discount all three genotype counts without the need to estimate p first. Note that
this sample size reduction is less severe than that to account for variance inflation in allele
frequency estimation, α = 0.6667.
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Yang, Gregersen, Li 12
α = 0.01 α = 0.05
p model using X2 using X2
e
using X2 using X2
e
0.1 R 0.022 0.011 0.082 0.054
A 0.022 0.011 0.083 0.051
D 0.019 0.009 0.078 0.051
0.3 R 0.022 0.011 0.073 0.048
A 0.020 0.009 0.078 0.049
D 0.022 0.010 0.082 0.052
0.5 R 0.022 0.011 0.082 0.053
A 0.020 0.009 0.078 0.050
D 0.022 0.010 0.082 0.053
Table 3: Empirical type I errors for the allele-based association test at the nominal significance level of 0.01
and 0.05, either by using the naive (uncorrected) X2 or the X2
e
modified by the effective sample size. The
allele frequencies in case and control group are the same, even though different simulation runs are labeled as
recessive (R), additive (A) and dominant (D).
Effective sample size method performs well in simulation and in comparing the
score test
Using the simulated data described in the Methods and Material section, we have checked
the validity of the effective sample size method. We first compare the test errors in using the
uncorrected chi-square test statistic X2 and the ESS-corrected X2e , for the allele-based test.
Table 3 shows the type I error under the null distribution in chi-square test using the naive X2
and ESS-corrected X2e . Note that for the null distribution, different disease model has no effect
on the allele/genotype frequencies, and we simply consider the R/A/D models in Table 3 as
three independent runs. It is clear that X2e leads to the more correct type I errors, practically
identical to the nominal significance, whereas the naive X2 clearly leads to larger type I errors.
The locally most powerful test among all tests with the correct type I errors is the score
test (Cox and Hinkley, 1974) which sets a standard other tests can be compared to. For allele-
based analysis, ESS-corrected X2e is identical to the score test, sharing the same power. For
genotype-based test (i.e. chi-square test on 2-by-3 genotype count table), chi-square test using
ESS-corrected X2e is not identical to the score test. Here we adopt the simplest ESS correction
for genotype data: multiplying the genotype counts by a constant reduction value α = 0.7096.
The power curve in Figure 2 shows that the difference between the ESS-corrected X2e test and
score test is negligible for dominant or additive disease models. The difference for recessive
models is non-zero, but nevertheless small.
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Discussion
Cheverud’s formula for the number of independent variables Based on the idea that
the overall amount of correlation among several variables can be measured by the variance of
the eigenvalues derived from their correlation matrix, Cheverud proposed a formula to calculate
the effective number of variables (Cheverud, 2001):
Ne = N
(
1− (N − 1)
V ar[λ]
N2
)
(13)
where N is the number of variables, and λ = (λ1, λ2, . . . λN) are the eigenvalues of the N ×N
correlation matrix for these N variables. Eq.(13) has been applied to QTL mapping in the
inbreeding system and to human association analysis to determine the number of independent
markers in a linkage disequilibrium block (Cheverud, 2001; Nyholt, 2004). Although this for-
mula has not been used to determine the number of independent samples, it can be interesting
to compare Eq.(13) with the ESS formula derived in this paper.
We consider the large sibship situation where the correlation matrix is characterized by
Eq.(4). It can be shown that each submatrix (the 3 × 3 block in Eq.(4)) contributes an
eigenvalue equal to 1 + (3 − 1)r = 1 + 2r, and two eigenvalues equal to 1 − r. The variance
of the eigenvalues for Eq.(4) is then equal to 2r2(N/(N − 1)). Inserting it to Eq.(13), we have
the Cheverud’s effective number of variables: N − 2r2. Compared to the ESS of N/(1 + 2r)
determined by Eq.(5), Cheverud’s formula leads to a larger effective number of degrees of
freedom, and less reduction, in particular in the large N limit.
We believe that our effective sample size formula makes better sense: in the three-sib sibship
case, because each sibship is independent of another, the number of independent samples is at
least N/3. Note that the ESS formula involves an operation of rescaling the original sample
size N, instead of subtracting a correction term. In order for Cheverud’s formula to have a
similar effect, the variance of eigenvalues has to increase with the sample size N . This can be
true only if there is a collective correlation for all variables, or if there is haplotype block-block
correlation. If the variables (samples) can be split into independent blocks, the effective degrees
of freedom (sample size) should always be a rescaled version of the original one. Interestingly,
for a model discussed in (Salyakina et al., 2005) where the correlation coefficient within a block
is 1 and those between blocks are small non-negative values, the effective number of variables
is indeed a rescaled value of the original number of variables.
The variance inflation factor in the genomic control method The genomic control
method in association studies was proposed in (Devlin and Roeder, 1999; Bacanu et al., 2000;
Devlin et al., 2001) to correct population stratification and “cryptic relatedness” between
samples. Despite differences in the mechanism for correlation, population stratification and
family clusters could have similar consequences, and this similarity is exploited in a unified
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framework for association studies of quantitative traits (Yu et al., 2006). In the genomic
control method, neutral markers are used to estimate the variance inflation factor λ, and λ is
used to divide the chi-square statistic: X2gc = X
2/λ for a modified test statistic. This can be
compared to our formula for an ESS-corrected chi-square test statistic in Eq.(10), X2e ≈ αX
2
(if the allele counts NA,con, NB,con in control group are not too small). In this approximation,
X2e ≈ X
2
gc if α = 1/λ.
Whether genomic control can correctly capture the population substructures is still under
debate (Devlin et al., 2004), with reports of either under- or over-correcting the correlation
depending on the number of markers used (Marchini et al., 2004; Ko¨hler and Bickebo¨ller,
2006), and its performance perhaps also depends on whether the markers used to estimate λ
are ancestral-informative or not. For whole genome association studies with a large number
of markers, it is recommended to use a Bayesian version of the genomic control (Devlin et al.,
2004). In our situation, we are correcting the known relatedness between samples, and there
is no issue of under- and over-correcting the test statistic.
One key debate on genomic control is whether X2gc follows a central or non-central chi-
square distribution (Gorroochurn et al., 2006). For a truly admixed population with a positive
Wright’s FST value, the variance of the allele frequency is V arp = p(1 − p)(FST − FST/N +
1/(2N)) (the inbreeding coefficient is assumed to be zero) (Weir, 1996), which is inflated by a
factor (FST−FST/N+1/(2N)). This admixture-induced variance inflation cannot be accounted
for by a simple sample size reduction, because even of the infinite sample limit the residual
variance is still nonzero. At the infinite sample size limit, the variance inflation factor is equal
to FST , which is why FST is also called the standardized measure of variance, or Wahlund’s
variance (Cavalli-Sforza and Bodmer, 1971). The only way to reconcile the variance inflation
and sample size reduction here is to set α = 1/(1+2(N−1)FST ), i.e., the sample size reduction
itself depends on sample size. All these issues in correcting admixed subpopulations are not
problematic for our relative samples because we assume the allele frequency does not change
from pedigree to pedigree.
Comparison to the generalized estimation equation approach The method of gen-
eralized estimation equation (GEE), similar to ESS method, has a goal of utilizing correlated
samples in an analysis (Liang and Zeger 1986; Hanley et al., 2003). However, one major
difference between GEE and ESS is that GEE relies on data to estimate the within-cluster
correlation among samples, whereas ESS calculates the correlation by the information given.
Typically in GEE, only a single correlation coefficient r is estimated for all clusters, which
can be unreliable if clusters of different natures are included in the data. For example, if the
dataset contains both sibpairs and cousin-pairs, the r for samples within sibpairs should be
larger than that for cousin-pairs. Another difference is that GEE corrects not only variance,
but also mean as well, whereas ESS only modifies variance. Similar to an argument made in
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(Devlin et al., 2004), we believe that sample correlation mainly affects the variance, and has
less effect on bias.
We use the IFIH1 genotype data in Table 5 to illustrate differences between GEE and ESS.
Using the corstr=“exchangeable” option in the gee subroutine in R statistical package (VJ
Carey, T Lumley, and B Ripley, “The gee package”, version 4.13-12, Feb 2007) , the averaged
within-family correlation coefficient for the allele count variable was estimated as r =0.4349.
This r value is slightly smaller than that for sibpairs (r =0.5), but close, reflecting the fact
that this dataset is dominated by sibpairs. In the Results section, we have shown that using
r = 0.5, the sample size reduction for the dataset in Table 5 is equal to 0.649. If we use the
within-group correlation coefficient r =0.4349 estimated by GEE, the sample size reduction
is 0.678. The GEE and ESS results are more or less the same, though GEE does not seem
to correct the correlation enough. A similar observation that GEE tends to underestimate
variance for smaller sample sizes was made in (Tre´goue¨t et al., 1997).
The estimation equation is essentially a procedure to determine weights of samples. When
samples are correlated, their weights are lower than 1. It was shown in (Hanley et al., 2003) that
the weight for sibpairs w that minimizes the variance is exactly equal to the Eq.(3) used in this
paper. We expect that in general, the weight of related samples determined by minimizing the
variance will be equal to the sample size reduction α if the weight for independent individuals
is set to 1.
In conclusion, among alternative approaches in handling correlated samples in genetic as-
sociation studies, such as likelihood-based approach (Bourgain et al., 2003), sample weighting
(Browning et al., 2005), and estimation equation (Tre´goue¨t et al., 1997), effective sample size
is perhaps the most accessible method: easier to use, and with no need to have new computer
software. Since the reason that correlated samples are often avoided in practice is not because
solutions do not exist, but because the existing methods are relatively hard to use, we believe
the ESS method discussed here will help medical geneticists to routinely use pedigree data in
association studies.
Methods and Materials
Data sets
A missense SNP rs2476601 in the protein tyrosine phosphatase non-receptor type 22 gene on
chromosome 1 (PTPN22) was shown to be associated with the autoimmune disease rheumatoid
arthritis (Begovich et al., 2004; Lee et al., 2005). The rheumatoid arthritis samples were
collected by the North American Rheumatoid Arthritis Consortium (NARAC) for genetic
linkage analysis (Jawaheer et al., 2001; Jawaheer et al., 2003), and all pedigrees contain two
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or more affected siblings. In the original report (Begovich et al., 2004), one sib per affected
sibpair is randomly selected from 377 affected sibpairs for the association analysis (plus 86
singletons). This procedure cuts the number of case samples almost by half. An association
analysis of all affected sibs with a correction of the correlation between sibs was not carried
out. We reproduce this dataset in Table 4 (corresponds to the “replication study” in Table 1
of (Begovich et al., 2004)).
Another dataset used here is the genotype of a non-synonymous SNP in IFIH1 gene on
chromosome 2, also collected by NARAC. IFIH1 gene has recently been shown to be associated
with type 1 diabetes (Smyth et al., 2006), but its association status with rheumatoid arthritis
is unknown. This dataset consists of 1344 independent control samples and 1328 case samples
distributed in 653 pedigrees – including 67 singletons, 512 affected relative-pairs (the majority
are affected sibpairs), 64 affected triples (most are sibship with 3 affected sibs), 8 affected
quadruples, and two pedigrees with 5 and 8 affecteds. The three genotype counts of this SNP
are listed in Table 5.
TT TC CC N Nallele=2N
case (86 singletons and 377 sibpairs) 21 241 578 840 1680
case (86 singletons and 377 sibs) 10 126 327 463 926
control 9 143 774 926 1852
Table 4: Genotype counts of a SNP in PTPN22 in human chromosome 1 in case (rheumatoid arthritis) and
control group. The first line summaries the genotype counts of all case samples, including 86 singletons
(uncorrelated samples) and 377 sibpairs. The second line is a subset of the case group with one affected sib
per pedigree (sibpair) randomly chosen. The third line is for the control group.
CC TC TT N Nallele=2N
case (all) 169 624 535 1328 2656
case (1 sample per ped) 87 308 258 653 1306
control 247 603 494 1344 2688
Table 5: Genotype counts of a SNP in IFIH1 gene in human chromosome 2 in case (rheumatoid arthritis) and
control group. Those of all case samples, of independent case samples, and of control samples, are listed in
lines 1,2, and 3.
Simulations
Simple simulated datasets were created for checking the effective sample size method as applied
to sibpair data. For each replicate, genotypes of 500 “case” samples consisting of 250 sibpairs
and 500 “control” samples were simulated. The genotype in control group was sampled from
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.4
00
.1
 : 
Po
st
ed
 9
 J
ul
 2
00
7
Yang, Gregersen, Li 17
the genotype distribution of Pcontrol(G) = (p
2, 2pq, q2) for genotypes AA, AB, BB. Those in
the case group is sampled by the model:
Pcase(G) ∝
ea+b·f(G)
1 + ea+b·f(G)
Pcontrol(G) (14)
where f(G) represents the disease models, a is the baseline log-odds, and b is the log-odds ratio.
The dominant model (D) is equivalent to f(G)=(1,1,0) for genotype AA, AB, BB; recessive
model (R) corresponds to f(G)=(1,0,0); and additive model (A) corresponds to f(G) = (1,
0.5, 0). For the null distribution to be used to check the type I error, b = 0, i.e, genotype has
no effect on the disease status, and Pcase = Pcontrol. For the alternative distribution to be used
to check the power, a is chosen at −4 and b is chosen between 0 and 0.5.
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Figure 1: (Upper row) expected variance of genotypes AA, AB, BB and allele A (multiplied by the sample
size) as a function of the allele frequency p(A). The solid line indicates the result from independent samples,
and dashed line from sibpairs. (Lower row) effective genotype count reduction α1, α2, α3 for sibpair data as a
function of p(A) (Eq.(12)). For allele count, the sample size reduction is a constant number of 2/3. The grey
line is the αa(p), the weighted average of α1, α2, α3. The α=0.7096 line is the average of αa(p) over p’s.
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Figure 2: Empirical power curve for the genotype-based test of three different models (recessive, additive,
dominant) at the nominal significance level of 0.01 (upper row) and 0.05 (lower row). The x-axis is the log-
odds ratio parameter b in the disease model Eq.(14). Two power curves are shown: using effective sample size
corrected X2
e
(solid line), and by the score test (dashed line).
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